Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Pet NSAIDs Market Research Report 2025

Global Pet NSAIDs Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-01-01

Pages: 99 Pages

Report ld: 3448956

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Pet NSAIDs was valued at US$ 37.8 million in the year 2024 and is projected to reach a revised size of US$ 49.9 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Pet Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation, and bring down a high temperature. They can relieve the pain caused by inflammation of the pet"s knee joint.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 46%.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Pet NSAIDs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet NSAIDs.

The Pet NSAIDs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet NSAIDs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pet NSAIDs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Zoetis

Elanco

PREVICOX

Metacam

Chanelle Pharma

AVENTIX

Woodruff

KRKA UK Ltd

Dechra

Parnell

VetUK

Norbrook

Alivira Animal Health

Vedco Inc

Vethical

Vetoquinol

Pivetal

Segment by Type

Carprofen

Deracoxib

Firocoxib

Meloxicam

Segment by Application

Dog

Cat

Horse

Others

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Pet NSAIDs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Pet NSAIDs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Pet NSAIDs Market Overview

1.1 Product Definition

1.2 Pet NSAIDs by Type

1.2.1 Global Pet NSAIDs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Carprofen

1.2.3 Deracoxib

1.2.4 Firocoxib

1.2.5 Meloxicam

1.3 Pet NSAIDs by Application

1.3.1 Global Pet NSAIDs Market Value by Application (2024 VS 2031)

1.3.2 Dog

1.3.3 Cat

1.3.4 Horse

1.3.5 Others

1.4 Global Pet NSAIDs Market Size Estimates and Forecasts

1.4.1 Global Pet NSAIDs Revenue 2020-2031

1.4.2 Global Pet NSAIDs Sales 2020-2031

1.4.3 Global Pet NSAIDs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Pet NSAIDs Market Competition by Manufacturers

2.1 Global Pet NSAIDs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Pet NSAIDs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Pet NSAIDs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Pet NSAIDs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Pet NSAIDs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Pet NSAIDs, Product Type & Application

2.7 Global Key Manufacturers of Pet NSAIDs, Date of Enter into This Industry

2.8 Global Pet NSAIDs Market Competitive Situation and Trends

2.8.1 Global Pet NSAIDs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Pet NSAIDs Players Market Share by Revenue

2.8.3 Global Pet NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Pet NSAIDs Market Scenario by Region

3.1 Global Pet NSAIDs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Pet NSAIDs Sales by Region: 2020-2031

3.2.1 Global Pet NSAIDs Sales by Region: 2020-2025

3.2.2 Global Pet NSAIDs Sales by Region: 2026-2031

3.3 Global Pet NSAIDs Revenue by Region: 2020-2031

3.3.1 Global Pet NSAIDs Revenue by Region: 2020-2025

3.3.2 Global Pet NSAIDs Revenue by Region: 2026-2031

3.4 North America Pet NSAIDs Market Facts & Figures by Country

3.4.1 North America Pet NSAIDs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Pet NSAIDs Sales by Country (2020-2031)

3.4.3 North America Pet NSAIDs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Pet NSAIDs Market Facts & Figures by Country

3.5.1 Europe Pet NSAIDs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Pet NSAIDs Sales by Country (2020-2031)

3.5.3 Europe Pet NSAIDs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Pet NSAIDs Market Facts & Figures by Region

3.6.1 Asia Pacific Pet NSAIDs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Pet NSAIDs Sales by Region (2020-2031)

3.6.3 Asia Pacific Pet NSAIDs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Pet NSAIDs Market Facts & Figures by Country

3.7.1 Latin America Pet NSAIDs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Pet NSAIDs Sales by Country (2020-2031)

3.7.3 Latin America Pet NSAIDs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Pet NSAIDs Market Facts & Figures by Country

3.8.1 Middle East and Africa Pet NSAIDs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Pet NSAIDs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Pet NSAIDs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Pet NSAIDs Sales by Type (2020-2031)

4.1.1 Global Pet NSAIDs Sales by Type (2020-2025)

4.1.2 Global Pet NSAIDs Sales by Type (2026-2031)

4.1.3 Global Pet NSAIDs Sales Market Share by Type (2020-2031)

4.2 Global Pet NSAIDs Revenue by Type (2020-2031)

4.2.1 Global Pet NSAIDs Revenue by Type (2020-2025)

4.2.2 Global Pet NSAIDs Revenue by Type (2026-2031)

4.2.3 Global Pet NSAIDs Revenue Market Share by Type (2020-2031)

4.3 Global Pet NSAIDs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Pet NSAIDs Sales by Application (2020-2031)

5.1.1 Global Pet NSAIDs Sales by Application (2020-2025)

5.1.2 Global Pet NSAIDs Sales by Application (2026-2031)

5.1.3 Global Pet NSAIDs Sales Market Share by Application (2020-2031)

5.2 Global Pet NSAIDs Revenue by Application (2020-2031)

5.2.1 Global Pet NSAIDs Revenue by Application (2020-2025)

5.2.2 Global Pet NSAIDs Revenue by Application (2026-2031)

5.2.3 Global Pet NSAIDs Revenue Market Share by Application (2020-2031)

5.3 Global Pet NSAIDs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Zoetis

6.1.1 Zoetis Company Information

6.1.2 Zoetis Description and Business Overview

6.1.3 Zoetis Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Zoetis Pet NSAIDs Product Portfolio

6.1.5 Zoetis Recent Developments/Updates

6.2 Elanco

6.2.1 Elanco Company Information

6.2.2 Elanco Description and Business Overview

6.2.3 Elanco Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Elanco Pet NSAIDs Product Portfolio

6.2.5 Elanco Recent Developments/Updates

6.3 PREVICOX

6.3.1 PREVICOX Company Information

6.3.2 PREVICOX Description and Business Overview

6.3.3 PREVICOX Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 PREVICOX Pet NSAIDs Product Portfolio

6.3.5 PREVICOX Recent Developments/Updates

6.4 Metacam

6.4.1 Metacam Company Information

6.4.2 Metacam Description and Business Overview

6.4.3 Metacam Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Metacam Pet NSAIDs Product Portfolio

6.4.5 Metacam Recent Developments/Updates

6.5 Chanelle Pharma

6.5.1 Chanelle Pharma Company Information

6.5.2 Chanelle Pharma Description and Business Overview

6.5.3 Chanelle Pharma Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Chanelle Pharma Pet NSAIDs Product Portfolio

6.5.5 Chanelle Pharma Recent Developments/Updates

6.6 AVENTIX

6.6.1 AVENTIX Company Information

6.6.2 AVENTIX Description and Business Overview

6.6.3 AVENTIX Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 AVENTIX Pet NSAIDs Product Portfolio

6.6.5 AVENTIX Recent Developments/Updates

6.7 Woodruff

6.7.1 Woodruff Company Information

6.7.2 Woodruff Description and Business Overview

6.7.3 Woodruff Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Woodruff Pet NSAIDs Product Portfolio

6.7.5 Woodruff Recent Developments/Updates

6.8 KRKA UK Ltd

6.8.1 KRKA UK Ltd Company Information

6.8.2 KRKA UK Ltd Description and Business Overview

6.8.3 KRKA UK Ltd Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 KRKA UK Ltd Pet NSAIDs Product Portfolio

6.8.5 KRKA UK Ltd Recent Developments/Updates

6.9 Dechra

6.9.1 Dechra Company Information

6.9.2 Dechra Description and Business Overview

6.9.3 Dechra Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Dechra Pet NSAIDs Product Portfolio

6.9.5 Dechra Recent Developments/Updates

6.10 Parnell

6.10.1 Parnell Company Information

6.10.2 Parnell Description and Business Overview

6.10.3 Parnell Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Parnell Pet NSAIDs Product Portfolio

6.10.5 Parnell Recent Developments/Updates

6.11 VetUK

6.11.1 VetUK Company Information

6.11.2 VetUK Description and Business Overview

6.11.3 VetUK Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 VetUK Pet NSAIDs Product Portfolio

6.11.5 VetUK Recent Developments/Updates

6.12 Norbrook

6.12.1 Norbrook Company Information

6.12.2 Norbrook Description and Business Overview

6.12.3 Norbrook Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Norbrook Pet NSAIDs Product Portfolio

6.12.5 Norbrook Recent Developments/Updates

6.13 Alivira Animal Health

6.13.1 Alivira Animal Health Company Information

6.13.2 Alivira Animal Health Description and Business Overview

6.13.3 Alivira Animal Health Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Alivira Animal Health Pet NSAIDs Product Portfolio

6.13.5 Alivira Animal Health Recent Developments/Updates

6.14 Vedco Inc

6.14.1 Vedco Inc Company Information

6.14.2 Vedco Inc Description and Business Overview

6.14.3 Vedco Inc Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Vedco Inc Pet NSAIDs Product Portfolio

6.14.5 Vedco Inc Recent Developments/Updates

6.15 Vethical

6.15.1 Vethical Company Information

6.15.2 Vethical Description and Business Overview

6.15.3 Vethical Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Vethical Pet NSAIDs Product Portfolio

6.15.5 Vethical Recent Developments/Updates

6.16 Vetoquinol

6.16.1 Vetoquinol Company Information

6.16.2 Vetoquinol Description and Business Overview

6.16.3 Vetoquinol Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Vetoquinol Pet NSAIDs Product Portfolio

6.16.5 Vetoquinol Recent Developments/Updates

6.17 Pivetal

6.17.1 Pivetal Company Information

6.17.2 Pivetal Description and Business Overview

6.17.3 Pivetal Pet NSAIDs Sales, Revenue and Gross Margin (2020-2025)

6.17.4 Pivetal Pet NSAIDs Product Portfolio

6.17.5 Pivetal Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Pet NSAIDs Industry Chain Analysis

7.2 Pet NSAIDs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Pet NSAIDs Production Mode & Process Analysis

7.4 Pet NSAIDs Sales and Marketing

7.4.1 Pet NSAIDs Sales Channels

7.4.2 Pet NSAIDs Distributors

7.5 Pet NSAIDs Customer Analysis

8 Pet NSAIDs Market Dynamics

8.1 Pet NSAIDs Industry Trends

8.2 Pet NSAIDs Market Drivers

8.3 Pet NSAIDs Market Challenges

8.4 Pet NSAIDs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Pet NSAIDs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Pet NSAIDs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Pet NSAIDs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Pet NSAIDs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Pet NSAIDs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Pet NSAIDs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Pet NSAIDs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Pet NSAIDs Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Pet NSAIDs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Pet NSAIDs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Pet NSAIDs, Product Type & Application

Table 12. Global Key Manufacturers of Pet NSAIDs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Pet NSAIDs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet NSAIDs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Pet NSAIDs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Pet NSAIDs Sales by Region (2020-2025) & (K Units)

Table 18. Global Pet NSAIDs Sales Market Share by Region (2020-2025)

Table 19. Global Pet NSAIDs Sales by Region (2026-2031) & (K Units)

Table 20. Global Pet NSAIDs Sales Market Share by Region (2026-2031)

Table 21. Global Pet NSAIDs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Pet NSAIDs Revenue Market Share by Region (2020-2025)

Table 23. Global Pet NSAIDs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Pet NSAIDs Revenue Market Share by Region (2026-2031)

Table 25. North America Pet NSAIDs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Pet NSAIDs Sales by Country (2020-2025) & (K Units)

Table 27. North America Pet NSAIDs Sales by Country (2026-2031) & (K Units)

Table 28. North America Pet NSAIDs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Pet NSAIDs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Pet NSAIDs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Pet NSAIDs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Pet NSAIDs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Pet NSAIDs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Pet NSAIDs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Pet NSAIDs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Pet NSAIDs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Pet NSAIDs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Pet NSAIDs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Pet NSAIDs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Pet NSAIDs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Pet NSAIDs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Pet NSAIDs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Pet NSAIDs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pet NSAIDs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Pet NSAIDs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Pet NSAIDs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Pet NSAIDs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Pet NSAIDs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Pet NSAIDs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Pet NSAIDs Sales (K Units) by Type (2020-2025)

Table 51. Global Pet NSAIDs Sales (K Units) by Type (2026-2031)

Table 52. Global Pet NSAIDs Sales Market Share by Type (2020-2025)

Table 53. Global Pet NSAIDs Sales Market Share by Type (2026-2031)

Table 54. Global Pet NSAIDs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Pet NSAIDs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Pet NSAIDs Revenue Market Share by Type (2020-2025)

Table 57. Global Pet NSAIDs Revenue Market Share by Type (2026-2031)

Table 58. Global Pet NSAIDs Price (US$/Unit) by Type (2020-2025)

Table 59. Global Pet NSAIDs Price (US$/Unit) by Type (2026-2031)

Table 60. Global Pet NSAIDs Sales (K Units) by Application (2020-2025)

Table 61. Global Pet NSAIDs Sales (K Units) by Application (2026-2031)

Table 62. Global Pet NSAIDs Sales Market Share by Application (2020-2025)

Table 63. Global Pet NSAIDs Sales Market Share by Application (2026-2031)

Table 64. Global Pet NSAIDs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Pet NSAIDs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Pet NSAIDs Revenue Market Share by Application (2020-2025)

Table 67. Global Pet NSAIDs Revenue Market Share by Application (2026-2031)

Table 68. Global Pet NSAIDs Price (US$/Unit) by Application (2020-2025)

Table 69. Global Pet NSAIDs Price (US$/Unit) by Application (2026-2031)

Table 70. Zoetis Company Information

Table 71. Zoetis Description and Business Overview

Table 72. Zoetis Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Zoetis Pet NSAIDs Product

Table 74. Zoetis Recent Developments/Updates

Table 75. Elanco Company Information

Table 76. Elanco Description and Business Overview

Table 77. Elanco Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Elanco Pet NSAIDs Product

Table 79. Elanco Recent Developments/Updates

Table 80. PREVICOX Company Information

Table 81. PREVICOX Description and Business Overview

Table 82. PREVICOX Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. PREVICOX Pet NSAIDs Product

Table 84. PREVICOX Recent Developments/Updates

Table 85. Metacam Company Information

Table 86. Metacam Description and Business Overview

Table 87. Metacam Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Metacam Pet NSAIDs Product

Table 89. Metacam Recent Developments/Updates

Table 90. Chanelle Pharma Company Information

Table 91. Chanelle Pharma Description and Business Overview

Table 92. Chanelle Pharma Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Chanelle Pharma Pet NSAIDs Product

Table 94. Chanelle Pharma Recent Developments/Updates

Table 95. AVENTIX Company Information

Table 96. AVENTIX Description and Business Overview

Table 97. AVENTIX Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. AVENTIX Pet NSAIDs Product

Table 99. AVENTIX Recent Developments/Updates

Table 100. Woodruff Company Information

Table 101. Woodruff Description and Business Overview

Table 102. Woodruff Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Woodruff Pet NSAIDs Product

Table 104. Woodruff Recent Developments/Updates

Table 105. KRKA UK Ltd Company Information

Table 106. KRKA UK Ltd Description and Business Overview

Table 107. KRKA UK Ltd Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. KRKA UK Ltd Pet NSAIDs Product

Table 109. KRKA UK Ltd Recent Developments/Updates

Table 110. Dechra Company Information

Table 111. Dechra Description and Business Overview

Table 112. Dechra Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Dechra Pet NSAIDs Product

Table 114. Dechra Recent Developments/Updates

Table 115. Parnell Company Information

Table 116. Parnell Description and Business Overview

Table 117. Parnell Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Parnell Pet NSAIDs Product

Table 119. Parnell Recent Developments/Updates

Table 120. VetUK Company Information

Table 121. VetUK Description and Business Overview

Table 122. VetUK Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. VetUK Pet NSAIDs Product

Table 124. VetUK Recent Developments/Updates

Table 125. Norbrook Company Information

Table 126. Norbrook Description and Business Overview

Table 127. Norbrook Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Norbrook Pet NSAIDs Product

Table 129. Norbrook Recent Developments/Updates

Table 130. Alivira Animal Health Company Information

Table 131. Alivira Animal Health Description and Business Overview

Table 132. Alivira Animal Health Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Alivira Animal Health Pet NSAIDs Product

Table 134. Alivira Animal Health Recent Developments/Updates

Table 135. Vedco Inc Company Information

Table 136. Vedco Inc Description and Business Overview

Table 137. Vedco Inc Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Vedco Inc Pet NSAIDs Product

Table 139. Vedco Inc Recent Developments/Updates

Table 140. Vethical Company Information

Table 141. Vethical Description and Business Overview

Table 142. Vethical Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Vethical Pet NSAIDs Product

Table 144. Vethical Recent Developments/Updates

Table 145. Vetoquinol Company Information

Table 146. Vetoquinol Description and Business Overview

Table 147. Vetoquinol Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 148. Vetoquinol Pet NSAIDs Product

Table 149. Vetoquinol Recent Developments/Updates

Table 150. Pivetal Company Information

Table 151. Pivetal Description and Business Overview

Table 152. Pivetal Pet NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 153. Pivetal Pet NSAIDs Product

Table 154. Pivetal Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Pet NSAIDs Distributors List

Table 158. Pet NSAIDs Customers List

Table 159. Pet NSAIDs Market Trends

Table 160. Pet NSAIDs Market Drivers

Table 161. Pet NSAIDs Market Challenges

Table 162. Pet NSAIDs Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of Pet NSAIDs

Figure 2. Global Pet NSAIDs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pet NSAIDs Market Share by Type: 2024 & 2031

Figure 4. Carprofen Product Picture

Figure 5. Deracoxib Product Picture

Figure 6. Firocoxib Product Picture

Figure 7. Meloxicam Product Picture

Figure 8. Global Pet NSAIDs Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Pet NSAIDs Market Share by Application: 2024 & 2031

Figure 10. Dog

Figure 11. Cat

Figure 12. Horse

Figure 13. Others

Figure 14. Global Pet NSAIDs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Pet NSAIDs Market Size (2020-2031) & (US$ Million)

Figure 16. Global Pet NSAIDs Sales (2020-2031) & (K Units)

Figure 17. Global Pet NSAIDs Average Price (US$/Unit) & (2020-2031)

Figure 18. Pet NSAIDs Report Years Considered

Figure 19. Pet NSAIDs Sales Share by Manufacturers in 2024

Figure 20. Global Pet NSAIDs Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Pet NSAIDs Players: Market Share by Revenue in Pet NSAIDs in 2024

Figure 22. Pet NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Pet NSAIDs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Pet NSAIDs Sales Market Share by Country (2020-2031)

Figure 25. North America Pet NSAIDs Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Pet NSAIDs Sales Market Share by Country (2020-2031)

Figure 29. Europe Pet NSAIDs Revenue Market Share by Country (2020-2031)

Figure 30. Germany Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Pet NSAIDs Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Pet NSAIDs Revenue Market Share by Region (2020-2031)

Figure 37. China Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Pet NSAIDs Sales Market Share by Country (2020-2031)

Figure 48. Latin America Pet NSAIDs Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Pet NSAIDs Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Pet NSAIDs Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. U.A.E Pet NSAIDs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Pet NSAIDs by Type (2020-2031)

Figure 58. Global Revenue Market Share of Pet NSAIDs by Type (2020-2031)

Figure 59. Global Pet NSAIDs Price (US$/Unit) by Type (2020-2031)

Figure 60. Global Sales Market Share of Pet NSAIDs by Application (2020-2031)

Figure 61. Global Revenue Market Share of Pet NSAIDs by Application (2020-2031)

Figure 62. Global Pet NSAIDs Price (US$/Unit) by Application (2020-2031)

Figure 63. Pet NSAIDs Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Pet NSAIDs in 2025? zhanKai

The global market size of Pet NSAIDs in 2025 was 37.8 Million USD.

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Pet NSAIDs market size from 2025 to 2031? shouQi

Which companies rank high in the global Pet NSAIDs market? shouQi

Related Reports

Global Pet NSAIDs Market Research Report 2024
Pet Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation, and bring down a high temperature. They can relieve the pain caused by inflammation of the pet's knee joint.
Published Date: 2024-01-21
Pages: 103
USD 2900.00
(Single User License)
Pet NSAIDs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Pet Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation, and bring down a high temperature. They can relieve the pain caused by inflammation of the pet's knee joint.
Published Date: 2024-01-11
Pages: 144
USD 3950.00
(Single User License)

Global Pet NSAIDs Market Research Report 2024
Pet Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation, and bring down a high temperature. They can relieve the pain caused by inflammation of the pet's knee joint.
Published: 2024-01-21
Pages: 103
USD 2900.00 (Single User License)
Pet NSAIDs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Pet Non-steroidal anti-inflammatory drugs (NSAIDs) are medicines that are widely used to relieve pain, reduce inflammation, and bring down a high temperature. They can relieve the pain caused by inflammation of the pet's knee joint.
Published: 2024-01-11
Pages: 144
USD 3950.00 (Single User License)